BRCA2 and breast cancer: In lung and breast cancer cells, long-term induced inactivation of BRCA2 leads to upregulation of interferon-stimulated genes and activation of the cGAS/STING/STAT pathway, confirming that inactivation of BRCA2 triggers cellular innate immune responses [50].